MYB and neoplasm: In support of our phenotypic observations made in tumor-derived organoids, the expression of MYB was also significantly down-regulated by the combined treatment of BBR and OPCs (FC = 0.40 vs control, P = 0.05 in patient #1; FC = 0.43 vs control, P = 0.03 in patient #2; Figure 6C).